Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.
Ridzon
R
R
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Meador
J
J
Maxwell
R
R
Higgins
K
K
Weismuller
P
P
Onorato
I M
IM
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000009:adverse effects*; D011718:Pyrazinamide / Q000009:adverse effects*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control
D000995:Antitubercular Agents; D011718:Pyrazinamide; D015242:Ofloxacin; D000410:Alanine Transaminase